Obese women are likelier to neglect contraception, obese men are more prone to impotence and both are far less sexually active than counterparts of normal weight, a study said on Wednesday.

Scientists say being fat can be bad for the bedroom, especially if you're a woman.

LONDON (Reuters) - British scientists have found three new genetic risk factors for testicular cancer, the most common form of the disease in young men, and say their findings should aid efforts for better treatments and earlier diagnosis.

Doctors reported gains against nearly every form of cancer at a conference that ended this week. Yet when Will Thomas heard about an advance against prostate cancer, he wanted to know just one thing: "Is it a cure?"

No cures from recent cancer advances, but gains may be bigger than they appear. Doctors reported gains against nearly every form of cancer at a conference that ended this week. Yet when Will Thomas heard about an advance against prostate cancer, he wanted to know just one thing: "Is it a cure?"

No cures from recent cancer advances, but gains may be bigger than they appear. Doctors reported gains against nearly every form of cancer at a conference that ended this week. Yet when Will Thomas heard about an advance against prostate cancer, he wanted to know just one thing: "Is it a cure?"

NEW YORK (Reuters Health) - Middle-aged men sit around looking forlorn, while their shadows appear to be having all the fun. The men are moody, they have low libido, and they lack energy.

A combination of radiation therapy and hormone treatment can cut by 43 percent the risk of death in men suffering from locally advanced or high-risk prostate cancer, a study unveiled here Sunday showed.

Radiation plus hormones boosts prostate cancer survival; new breast cancer drug shows promise. Doctors are reporting a key advance in treating men with cancer that has started to spread beyond the prostate: survival is significantly better if radiation is added to standard hormone treatments.

Doctors are reporting a key advance in treating men with cancer that has started to spread beyond the prostate: survival is significantly better if radiation is added to standard hormone treatments.

Radiation plus hormones boosts prostate cancer survival; new breast cancer drug shows promise. Doctors are reporting a key advance in treating men with cancer that has started to spread beyond the prostate: survival is significantly better if radiation is added to standard hormone treatments.

CHICAGO (Reuters) - A third pivotal trial of Amgen Inc's denosumab found that it significantly delayed the likelihood of suffering fractures and other bone complications in men with advanced prostate cancer compared with current therapy.

CHICAGO (Reuters) - A third pivotal trial of Amgen Inc's denosumab found that it delayed by 21 percent the risk of fractures and other bone complications in men with advanced prostate cancer compared with current therapy.

CHICAGO (Reuters) - A highly sensitive blood test may be able to predict whether prostate cancer is cured or is likely to come back, giving doctors an early sign of whether treatments are working, U.S. researchers said Wednesday.

The size of a cancerous prostate tumor is directly proportional to the weight of the patient and the bigger the tumor the more aggressive the cancer, a study published Wednesday has found.

WASHINGTON (Reuters) - A urine test can help doctors better spot prostate cancer than either the current blood test or a rectal exam alone, U.S. researchers reported on Tuesday.

US actor and director Dennis Hopper, a counterculture icon who worked with Hollywood legends including James Dean and Marlon Brando, died Saturday at age 74, his manager said.

US actor and director Dennis Hopper, a counterculture icon who worked with Hollywood legends including James Dean and director Francis Ford Coppola, has died at age 74, US media reported Saturday.

US actor and director Dennis Hopper, a counterculture icon who worked with Hollywood legends including James Dean and director Francis Ford Coppola, has died at age 74, US media reported Saturday.

PARIS (Reuters) - Sanofi-Aventis' cabazitaxel candidate prostate cancer drug combined with prednisone reduced the risk of death by 28 percent compared with another treatment, the outcome of a final-stage trial showed.